Matches in SemOpenAlex for { <https://semopenalex.org/work/W3181987947> ?p ?o ?g. }
- W3181987947 endingPage "262" @default.
- W3181987947 startingPage "253" @default.
- W3181987947 abstract "This study was conducted to compare the similarity of the pharmacokinetics (PKs), safety, and immunogenicity of GB222, a potential bevacizumab biosimilar, to that of reference bevacizumab in Chinese healthy males.This was a randomized, double-blind, single-dose, parallel-group clinical trial performed in 84 Chinese healthy males, who were randomly assigned to receive a single infusion dose of 1 mg/kg GB222 or bevacizumab with an 84-days follow-up. The primary endpoint was the area under the plasma concentration-time curve (AUC) from zero to the last quantifiable concentration at time t (AUC0-t). The second endpoints were the safety and immunogenicity evaluation. The PK bioequivalence was verified by the 90% confidence intervals (CIs) of the geometrical mean (GM) ratio for AUC0-t falling within the bioequivalence margin, 80-125%.The PK profiles of GB222 and bevacizumab were comparable. The 90% CIs of GM ratio of GB222 to bevacizumab for AUC0-t was within the pre-specified bioequivalence margin. The most common treatment-related adverse event was sinus bradycardia. Seventeen subjects (20.2%) tested positive for anti-drug antibodies (ADAs).GB222 was found to be comparable to bevacizumab in terms of PKs, safety, and immunogenicity for Chinese healthy males.ChiCTR-IIR-17,011,143." @default.
- W3181987947 created "2021-07-19" @default.
- W3181987947 creator A5006654573 @default.
- W3181987947 creator A5011386079 @default.
- W3181987947 creator A5013395751 @default.
- W3181987947 creator A5021463359 @default.
- W3181987947 creator A5022184579 @default.
- W3181987947 creator A5026660885 @default.
- W3181987947 creator A5026939069 @default.
- W3181987947 creator A5044913842 @default.
- W3181987947 creator A5046225712 @default.
- W3181987947 creator A5052298016 @default.
- W3181987947 creator A5053448155 @default.
- W3181987947 creator A5054479691 @default.
- W3181987947 creator A5055740291 @default.
- W3181987947 creator A5065749705 @default.
- W3181987947 creator A5067624869 @default.
- W3181987947 creator A5076248068 @default.
- W3181987947 creator A5077556517 @default.
- W3181987947 creator A5082090695 @default.
- W3181987947 date "2021-07-26" @default.
- W3181987947 modified "2023-09-30" @default.
- W3181987947 title "Pharmacokinetic bioequivalence, safety, and immunogenicity of GB222, a bevacizumab biosimilar candidate, and bevacizumab in Chinese healthy males: a randomized clinical trial" @default.
- W3181987947 cites W1586042412 @default.
- W3181987947 cites W2012368323 @default.
- W3181987947 cites W2032754679 @default.
- W3181987947 cites W2062756251 @default.
- W3181987947 cites W2079150475 @default.
- W3181987947 cites W2095572961 @default.
- W3181987947 cites W2097701321 @default.
- W3181987947 cites W2122666323 @default.
- W3181987947 cites W2144660856 @default.
- W3181987947 cites W2145224595 @default.
- W3181987947 cites W2145835533 @default.
- W3181987947 cites W2255518001 @default.
- W3181987947 cites W2298790377 @default.
- W3181987947 cites W2483104935 @default.
- W3181987947 cites W2582613071 @default.
- W3181987947 cites W2732889090 @default.
- W3181987947 cites W2752880203 @default.
- W3181987947 cites W2756427986 @default.
- W3181987947 cites W2811001329 @default.
- W3181987947 cites W2889646458 @default.
- W3181987947 cites W2893646688 @default.
- W3181987947 cites W2911388614 @default.
- W3181987947 cites W2921434986 @default.
- W3181987947 cites W2921716909 @default.
- W3181987947 cites W2941607706 @default.
- W3181987947 cites W2953411802 @default.
- W3181987947 cites W2954920819 @default.
- W3181987947 cites W2964048033 @default.
- W3181987947 cites W2964471257 @default.
- W3181987947 cites W2973908960 @default.
- W3181987947 cites W2998001174 @default.
- W3181987947 cites W3038021296 @default.
- W3181987947 cites W3108776030 @default.
- W3181987947 doi "https://doi.org/10.1080/14712598.2021.1954157" @default.
- W3181987947 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34236011" @default.
- W3181987947 hasPublicationYear "2021" @default.
- W3181987947 type Work @default.
- W3181987947 sameAs 3181987947 @default.
- W3181987947 citedByCount "2" @default.
- W3181987947 countsByYear W31819879472023 @default.
- W3181987947 crossrefType "journal-article" @default.
- W3181987947 hasAuthorship W3181987947A5006654573 @default.
- W3181987947 hasAuthorship W3181987947A5011386079 @default.
- W3181987947 hasAuthorship W3181987947A5013395751 @default.
- W3181987947 hasAuthorship W3181987947A5021463359 @default.
- W3181987947 hasAuthorship W3181987947A5022184579 @default.
- W3181987947 hasAuthorship W3181987947A5026660885 @default.
- W3181987947 hasAuthorship W3181987947A5026939069 @default.
- W3181987947 hasAuthorship W3181987947A5044913842 @default.
- W3181987947 hasAuthorship W3181987947A5046225712 @default.
- W3181987947 hasAuthorship W3181987947A5052298016 @default.
- W3181987947 hasAuthorship W3181987947A5053448155 @default.
- W3181987947 hasAuthorship W3181987947A5054479691 @default.
- W3181987947 hasAuthorship W3181987947A5055740291 @default.
- W3181987947 hasAuthorship W3181987947A5065749705 @default.
- W3181987947 hasAuthorship W3181987947A5067624869 @default.
- W3181987947 hasAuthorship W3181987947A5076248068 @default.
- W3181987947 hasAuthorship W3181987947A5077556517 @default.
- W3181987947 hasAuthorship W3181987947A5082090695 @default.
- W3181987947 hasBestOaLocation W31819879472 @default.
- W3181987947 hasConcept C112705442 @default.
- W3181987947 hasConcept C126322002 @default.
- W3181987947 hasConcept C143998085 @default.
- W3181987947 hasConcept C159654299 @default.
- W3181987947 hasConcept C168563851 @default.
- W3181987947 hasConcept C197934379 @default.
- W3181987947 hasConcept C203014093 @default.
- W3181987947 hasConcept C203092338 @default.
- W3181987947 hasConcept C2776694085 @default.
- W3181987947 hasConcept C2777802072 @default.
- W3181987947 hasConcept C2780868878 @default.
- W3181987947 hasConcept C42404028 @default.
- W3181987947 hasConcept C535046627 @default.
- W3181987947 hasConcept C59491497 @default.
- W3181987947 hasConcept C71924100 @default.